Details for New Drug Application (NDA): 091124
✉ Email this page to a colleague
The generic ingredient in ESZOPICLONE is eszopiclone. There are twenty drug master file entries for this compound. Twenty-nine suppliers are listed for this compound. Additional details are available on the eszopiclone profile page.
Summary for 091124
| Tradename: | ESZOPICLONE |
| Applicant: | Lupin Ltd |
| Ingredient: | eszopiclone |
| Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 091124
Suppliers and Packaging for NDA: 091124
| Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
|---|---|---|---|---|---|---|---|---|
| ESZOPICLONE | eszopiclone | TABLET;ORAL | 091124 | ANDA | PD-Rx Pharmaceuticals, Inc. | 43063-795 | 43063-795-30 | 30 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (43063-795-30) |
| ESZOPICLONE | eszopiclone | TABLET;ORAL | 091124 | ANDA | Lupin Pharmaceuticals, Inc. | 68180-322 | 68180-322-01 | 100 TABLET, FILM COATED in 1 BOTTLE (68180-322-01) |
Profile for product number 001
| Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | 1MG | ||||
| Approval Date: | Sep 13, 2011 | TE: | AB | RLD: | No | ||||
Profile for product number 002
| Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | 2MG | ||||
| Approval Date: | Sep 13, 2011 | TE: | AB | RLD: | No | ||||
Profile for product number 003
| Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | 3MG | ||||
| Approval Date: | Sep 13, 2011 | TE: | AB | RLD: | No | ||||
Complete Access Available with Subscription
